These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 6210423

  • 1. Cardiovascular dopamine receptors: recent advances in agonists and antagonists of the DA1-receptor.
    Berkowitz BA, Ohlstein EH.
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S559-63. PubMed ID: 6210423
    [Abstract] [Full Text] [Related]

  • 2. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [Abstract] [Full Text] [Related]

  • 3. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526.
    Ohlstein EH, Zabko-Potapovich B, Berkowitz BA.
    J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817
    [Abstract] [Full Text] [Related]

  • 4. Role of dopaminergic and adrenergic receptors in the pathogenesis of arterial lesions induced by fenoldopam mesylate and dopamine in the rat.
    Kerns WD, Arena E, Morgan DG.
    Am J Pathol; 1989 Aug; 135(2):339-49. PubMed ID: 2571297
    [Abstract] [Full Text] [Related]

  • 5. Dopamine and dopamine receptors as target sites for cardiovascular drug action.
    Berkowitz BA.
    Fed Proc; 1983 Oct; 42(13):3019-21. PubMed ID: 6137421
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pathogenesis of arterial lesions induced by dopaminergic compounds in the rat.
    Kerns WD, Arena E, Macia RA, Bugelski PJ, Matthews WD, Morgan DG.
    Toxicol Pathol; 1989 Oct; 17(1 Pt 2):203-13. PubMed ID: 2568682
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA, Wardell JR, Sarau HM, Ridley PT.
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Action of fenoldopam, a selective dopamine (DA1) receptor agonist, on isolated human arteries.
    Hughes AD, Sever PS.
    Blood Vessels; 1989 Nov; 26(2):119-27. PubMed ID: 2474340
    [Abstract] [Full Text] [Related]

  • 13. Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    Grega GJ, Barrett RJ, Adamski SW, Lokhandwala MF.
    J Pharmacol Exp Ther; 1984 Jun; 229(3):756-62. PubMed ID: 6144791
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of dopamine and fenoldopam, a selective dopamine-1 agonist, on parathyroid hormone release in man.
    Bakris GL, Weber RR, Nelson K, Elliott WJ, Kaplan E, Murphy MB.
    Miner Electrolyte Metab; 1988 Jun; 14(6):343-6. PubMed ID: 2906737
    [Abstract] [Full Text] [Related]

  • 15. The DA1 receptor agonist fenoldopam (SK & F 82526) is also an alpha 2-adrenoceptor antagonist.
    Ohlstein EH, Zabko-Potapovich B, Berkowitz BA.
    Eur J Pharmacol; 1985 Dec 03; 118(3):321-9. PubMed ID: 2867915
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM.
    Eur J Pharmacol; 1986 Jul 15; 126(1-2):167-70. PubMed ID: 2875883
    [Abstract] [Full Text] [Related]

  • 18. Effect of dopamine on the cyclic adenosine monophosphate generating system in the rabbit internal carotid and middle cerebral artery.
    Amenta D, Cavallotti C, Collier WL, De Rossi M, Ricci A, Amenta F.
    Arch Int Pharmacodyn Ther; 1988 Jul 15; 291():96-103. PubMed ID: 2835025
    [Abstract] [Full Text] [Related]

  • 19. Bulbocapnine is not a selective DA1 receptor antagonist.
    Kohli JD, Glock D, Goldberg LI.
    J Pharm Pharmacol; 1986 May 15; 38(5):401-2. PubMed ID: 2872323
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.